Literature DB >> 12490577

Hydrophobic and ionic factors in the binding of local anesthetics to the major variant of human alpha1-acid glycoprotein.

Saeed Taheri1, Lawrence P Cogswell, Alison Gent, Gary R Strichartz.   

Abstract

Understanding the interaction of local anesthetics (LAs) with plasma proteins is essential to understanding their systemic pharmacology and toxicology. The molecular determinants of LA binding to the major variant (F1*S) of human alpha1-acid glycoprotein (AGP) were therefore investigated spectrofluorometrically using whole AGP and a novel, F1*S variant-selective probe previously developed in our laboratory. Equilibrium- competitive displacement of this probe by LAs, observed by the recovery of AGP's fluorescence as the quenching probe was displaced from its high-affinity site, was characterized by inhibitory dissociation constants for the various LAs. The importance of electrostatic factors was assessed by examining the pH dependent binding of an ionizable LA, lidocaine, using the quaternary lidocaine derivative QX-314 [N-(2,6-dimethylphenylcarbamoylmethyl) triethylammonium chloride] to control for pH dependent ionization of AGP. Uncharged lidocaine bound with at least 8 times the affinity of protonated lidocaine (K(D) = 4.0 +/- 0.6 microM and >32 microM, respectively). This result is inconsistent with the current model of the AGP-binding site, which depicts a buried pocket having a negatively charged region that interacts with the amino termini of basic drugs. Consistent with the model, however, two sets of structurally homologous LAs (mepivacaine, ropivacaine, bupivacaine, and lidocaine, RAD-240, RAD-241, RAD-242, L-30, W-6603) demonstrated a strong positive correlation between hydrophobicity (measured as the octanol:buffer partition coefficient of the neutral species) and their free energies of dissociation. Given that the tertiary structure of AGP has proven refractory to resolution, these structure-activity studies should contribute to understanding the nature of the binding site on this important protein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12490577     DOI: 10.1124/jpet.102.042028

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  High-throughput analysis of drug dissociation from serum proteins using affinity silica monoliths.

Authors:  Michelle J Yoo; David S Hage
Journal:  J Sep Sci       Date:  2011-06-10       Impact factor: 3.645

2.  Tryptophan residues play an important role in the extraordinarily high affinity binding interaction of UCN-01 to human alpha-1-acid glycoprotein.

Authors:  Masaaki Katsuki; Victor Tuan Giam Chuang; Koji Nishi; Ayaka Suenaga; Masaki Otagiri
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

3.  Drug-binding energetics of human α-1-acid glycoprotein assessed by isothermal titration calorimetry and molecular docking simulations.

Authors:  Johnny X Huang; Matthew A Cooper; Mark A Baker; Mohammad A K Azad; Roger L Nation; Jian Li; Tony Velkov
Journal:  J Mol Recognit       Date:  2012-12       Impact factor: 2.137

4.  A Chronic Fatigue Syndrome - related proteome in human cerebrospinal fluid.

Authors:  James N Baraniuk; Begona Casado; Hilda Maibach; Daniel J Clauw; Lewis K Pannell; Sonja Hess S
Journal:  BMC Neurol       Date:  2005-12-01       Impact factor: 2.474

5.  Chiral probes for α1-AGP reporting by species-specific induced circularly polarised luminescence.

Authors:  Sergey Shuvaev; Elizaveta A Suturina; Kevin Mason; David Parker
Journal:  Chem Sci       Date:  2018-02-19       Impact factor: 9.825

6.  Hyperbaric spinal ropivacaine in lower limb and hip surgery: A comparison with hyperbaric bupivacaine.

Authors:  Feroz Ahmad Dar; Mohsin Bin Mushtaq; Umar Mushtaq Khan
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.